Course info
Description
As the premier event in malignant and non-malignant hematology, the ASH annual meeting provides attendees with an outstanding educational experience that examines the latest clinical advances in hematology and explores the year's most significant scientific discoveries and updates. The videos make this event available for convenient, on-demand viewing.
ASH offers four package options, where you can choose between scientific and educational content, purchase both at a lower price, or purchase the complete meeting including oral abstracts.
The 2024 ASH Annual Meeting Education Program package includes all of the following sessions:
- Marquee Sessions
- Education Program Sessions
- Special-Interest Sessions
- Spotlight Sessions
- Trainee Simultaneous Didactic Sessions
Sections
General
0 activities
Education Program
0 activities
A Little Less Conversation, a Little More Action: An Outcome Equity Roadmap for Children and AYAs With Leukemia and Lymphoma
3 activities
A Shifting Landscape: Treatment of MCL
4 activities
ALPS, CVID, and LGL: When Autoimmune Cytopenias Are a Marker of Underlying Immune Disease
4 activities
AML M&Ms: How to Integrate Mutations and MRD Data
4 activities
Addressing Unmet Needs in T Cell Lymphomas
4 activities
Adult ALL Advancements: Optimizing Cure in 2024
4 activities
Adult CAR-T Outcomes: Beyond the Acronyms (OS, PFS, CRS, ICANS)
4 activities
Anticoagulation SOS: Navigating Monitoring Conundrums
4 activities
Beyond TTP: “Atypical” TMAs for the Hematologist
4 activities
Challenges and Opportunities of Sickle Cell Care in Africa
4 activities
Challenges in Cancer-Associated Thrombosis
4 activities
Chasing Zebras: Navigating Rare Myeloid Neoplasms
4 activities
Follicular Lymphoma: Playing the Long Game
4 activities
HIT-and-Run: Challenges in Diagnosis and Management of Heparin-Induced Thrombocytopenia
4 activities
Handling Bad News: How to Best Manage TP53 Myeloid Disease?
4 activities
Hematologic Challenges at the End-of-Life
4 activities
Hematologic Management of the Patient with Heavy Menstrual Bleeding
4 activities
Integrating New Therapies into the Management of Classical Heme Disorders
3 activities
Ironing Out the Wrinkles: Managing Iron Overload in Different Clinical Scenarios
4 activities
It's a Different World: CLL 2024
4 activities
MPN Practice Pearls: Profiling, Pegylated IFN and Pregnancy
4 activities
Monoclonal Gammopathies: When the Clone Is More Than a Positive Laboratory Finding
4 activities
Moving the Needle in Hodgkin Lymphoma
4 activities
Newly Diagnosed Multiple Myeloma: Many Choices and More Questions
4 activities
Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
4 activities
Optimizing Non-Curative Therapies for Sickle Cell Disease
4 activities
Overcoming Post-transplant Relapse: How to Win the Battle Royale
3 activities
Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
4 activities
The Expanding Landscape of Treatment for ITP
4 activities
Vascular Anomalies, Vascular Malformations, and the Role of the Hematologist
4 activities
30
87